Serpin fusion polypeptides and methods of use thereof
AssigneeInhibrx, Inc.
InventorsBrendan P. Eckelman, John C. Timmer, Quinn Deveraux
Life of this patent
Estimating the term…
Loading patent…
AssigneeInhibrx, Inc.
InventorsBrendan P. Eckelman, John C. Timmer, Quinn Deveraux
Estimating the term…
This invention relates to molecules, particularly polypeptides, more particularly fusion proteins that include a serpin polypeptide or an amino acid sequence that is derived from a serpin and second polypeptide comprising of at least one the following: an Fc polypeptide or an amino acid sequence that is derived from an Fc polypeptide; a cytokine targeting polypeptide or a sequence derived from a cytokine targeting polypeptide; a WAP domain containing polypeptide or a sequence derived from a WAP containing polypeptide; and an albumin polypeptide or an amino acid sequence that is derived from a serum albumin polypeptide. This invention also relates to methods of using such molecules in a variety of therapeutic and diagnostic indications, as well as methods of producing such molecules.
An isolated fusion protein comprising at least one human serpin polypeptide operably linked to a human immunoglobulin Fc polypeptide or an amino acid sequence that is derived from an immunoglobulin Fc polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NOs:
Dependencies are inferred from the claim text.